1/ “Accidental” Intravenous (IV) injection of mRNA vaccine induces myopericarditis (inflammation of the heart), elevated troponin, infiltration of inflammatory cells, cardiomyocyte degeneration, necrosis and apoptosis of cardiac cells, edema, and pericardial calcification.
2/ The histological changes of myopericarditis after the first IV-priming dose persisted for 2 weeks and were markedly aggravated by a second IM- or IV-booster dose.
3/ Ballooning degeneration of hepatocytes (liver cells) was consistently found in the IV group.
4/ This study provided in-vivo evidence that inadvertent intravenous injection of COVID-19 mRNA-vaccines may induce myopericarditis. Authors recommend that brief withdrawal of syringe plunger to exclude blood aspiration may be one possible way to reduce such risk.
5/ The authors cannot exclude the possibility of myopericarditis developing in individuals who may be more susceptible to even a slight amount of mRNA vaccine entering the systemic circulation from intramuscular (IM) injection.
6/ Large whitish patches (arrows) were seen on the visceral pericardium of mice receiving IV vaccine.
7/ Inflammatory infiltrates of the myocardium; calcific deposits; cardiomyocyte degeneration; cardiomyocyte necrosis;
8/ Hepatocyte (liver cell) necrosis and ballooning degenerative changes of hepatocytes. Immunohistochemistry staining of spike RBD protein in liver sections at 2 days post IV vaccine.
9/ “Further research into the potential association of COVID-19 mRNA vaccination and autoimmune hepatitis is required.”
1/ In a new preprint, a group of research organizations analyzed VA records for ~620K people to monitor the change in vaccine efficacy over time. By August, protection against infection had declined to: 3% for J&J; 64% for Moderna; and 50% for Pfizer.
2/“In summary, although vax remains protective against infection, this protection is waning as the Delta var. has emerged in the U.S. It is not yet clear whether reductions in vax protection against inf. will translate into similar reductions in protection against hosp. & death.”
3/“Patterns of breakthrough SARS-CoV-2 infection among vaccinated Veterans show a worrisome temporal trend, overlapping with the emergence of Delta as the dominant variant in July 2021.”
1/ Does a large part of society really not understand why it’s a really bad idea to use mRNA or viral vector DNA to “vaccinate” someone who has natural immunity to COVID? Do people really not know what the immune system does to cells that express antigens on their surface?
2/ The immune system takes antigen-expressing cells out of commission via Cytotoxic T Cells (CD8+), Antibody-Dependent Cell-Mediated Cytotoxicity, and the Classical Pathway of the Complement System via Complement Dependent Lysis (CDL).
3/ Since mRNA lipid nanoparticles have access to many cell types via circulation, we have to assume that a great diversity of cells in different tissues become Spike-protein expressing factories. The spike protein on the surface of these cells targets them for immune attack.
1/ This research proves that the mRNA vaccines induce circulating Spike protein (not localized to injection site) for up to 4 months. Spike is released from cells via the induction of exosomes, which are extracellular ~100nm sized vesicles used in cell-to-cell communication.
2/ “Results demonstrated induction of circulating exosomes expressing spike protein on day 14 after vaccination followed by Abs 14 d after the second dose.”
3/ “Exosomes with spike protein, Abs to SARS-CoV-2 spike, and T cells secreting IFN-γ and TNF-α increased following the booster dose.”
1/ Any fellow molecular biologists want to attempt answering this question: What is the probability that the tropism of the virus shifts due to vaccine-accelerated Spike evolution leading to binding of novel receptors other than ACE2?
2/ Since vaccine roll out, the Spike ORF has exhibited high mutation rates and entropy.
3/ If the structure of Spike shifts far enough away where it gains the ability to dock to another transmembrane protein (while maintaining proteolytic conversion via TMPRSS2 or other like protease), the virus could preferentially gain access to other cell/tissue types.
1/ Vaccination Math = Let’s assuredly kill K% of people now and medically harm H% of people now because X% and Y% may (or may not) die and be harmed later.
To assess risk/reward, you need to know K, H, X, and Y. You also need a factor to account for the future “may or may not.”
2/ The factors that play into “may or may not” include modeling the herd immunity threshold (natural), viral evolution/attenuation rate, AND the adoption of current and new treatments, among other factors. We’ll call this factor “M”.
3/ Honest question: Do you think the powers that be did this type of math before pulling the trigger on the unprecedented campaign to vaccinate every person on the planet?
1/ Myocarditis rates reported in VAERS were significantly higher in youths between the ages of 13 to 23 (p<0.0001) with ∼80% occurring in males. They found 19 times the expected number of myocarditis cases in the vaccination volunteers over background.
2/ In addition, a 5-fold increase in myocarditis rate was observed subsequent to dose 2 as opposed to dose 1 in 15-year-old males.
3/ Of the total myocarditis reports, 6 individuals died (1.1%) and of these, 2 were under 20 years of age - 1 was 13.